Best Infectious Disease Medical Billing Services

An example of medical billing is submitting a claim for an infectious disease office visit, hospital consult, infusion administration, or drug. The claim communicates the service performed, supporting documentation, applicable coding, payer information, and requested reimbursement. In infectious disease practice, billing may also involve authorization, medical or pharmacy benefit determination, drug acquisition details, payment reconciliation, denial follow-up, and collection of the remaining balance.

Physician-visit CPT coding depends on the type of encounter, whether the patient is new or established, the setting, and the documentation supporting the service. A code should not be selected from a generic list without reviewing the actual record and current coding guidance. Infectious disease practices should also consider consult, hospital, infusion, drug, and related services when evaluating the complete claim and reimbursement workflow.

Infectious disease medical billing can include charge entry, coding review, claim scrubbing, submission, rejection clearing, denial management, payment reconciliation, A/R follow-up, eligibility verification, prior authorization, and payer compliance review. It may cover office visits, hospital consults, infusion administration, OPAT services, and drug claims. The exact workflow depends on the practice’s services, systems, contracts, documentation, and coverage arrangements.

Infectious disease practices may combine cognitive physician services with infusion operations, OPAT, drug acquisition, specialty medications, hospital coverage agreements, and multiple reimbursement pathways. Claims can be affected by authorization, medical versus pharmacy benefit rules, documentation, units, drug identifiers, and payer contracts. A useful billing review therefore examines the full revenue cycle rather than treating office-visit claims as the practice’s only financial activity.

Revenue leakage can be investigated by reviewing reports by payer, service line, and provider, then comparing billed work, expected reimbursement, received payments, denials, and aging balances. Common sources may include under-leveled visits, uncaptured drug or administration charges, missing authorization, documentation gaps, contract application issues, and unpursued balances. The objective is to trace each gap to documentation, charge capture, coding, workflow, or contract causes.

Denial management is the structured review, categorization, appeal, and prevention of rejected or unpaid claims. For infectious disease services, denial causes may involve drug and administration coding, missing authorization, medical versus pharmacy benefit confusion, or under-documented consults. Effective work addresses the individual claim with appropriate support while also sending recurring findings to clinical, coding, and front-office teams so preventable patterns can be reduced.

Payment reconciliation compares received reimbursement with the expected payment for drug, administration, and evaluation and management claims. The review may identify short-pays, incorrect fee schedule application, unit mismatches, or NDC mismatches. Findings can then be disputed and tracked through recovery. Practices should organize the review by payer and service details so discrepancies are documented clearly and recurring payment issues can be evaluated.

Yes. Credentialing and payer enrollment support may include CAQH, commercial and government payer enrollment, and re-credentialing for physicians and APPs. Infectious disease practices may also need enrollment related to infusion and OPAT services, sites, and distinct revenue streams. The purpose is to help ensure that each applicable provider, site, and service is properly enrolled before billing begins, subject to payer requirements and practice circumstances.